Novel 1,2,4,5-tetraoxane cyclic peroxide compounds with diverse biological activities
A library of structurally diverse 1,2,4,5-tetraoxane cyclic peroxide compounds synthesized from carbonyls and hydrogen peroxide. These spiro phenyl-substituted analogs are designed to induce oxidative cellular damage and demonstrate a wide range of biological activities, including potential applications as herbicides and therapeutic agents.
Overview
This offering presents a collection of novel 1,2,4,5-tetraoxane cyclic peroxide compounds synthesized through a chemistry-driven approach. These molecules feature two peroxide moieties within a six-membered ring, providing a structurally diverse scaffold with a wide range of demonstrated biological activities. The research hypothesis is that these compounds can induce oxidative damage in target cells, making them promising candidates for applications such as herbicides and potential pharmaceutical interventions. The synthesis leverages template catalysis and hydrogen peroxide activation to generate unique molecular architectures, including spiro phenyl-substituted analogs predicted to exhibit similar bioactivity profiles.
Technical specifications
- Core chemistry: 1,2,4,5-tetraoxane scaffolds containing two peroxide bonds within a six-membered ring
- Synthesis route: Prepared from two carbonyl precursors and hydrogen peroxide, enabling structural diversity
- Catalysis approach: Template catalysis combined with H2O2 activation to produce novel molecular frameworks
- Key analogs: Spiro phenyl-substituted tetraoxanes designed for enhanced biological activity
- Biological profile: Compounds designed to cause oxidative damage to cells, with proven activities including herbicidal applications
- Structural flexibility: The synthetic methodology allows for systematic variation of substituents to tune biological properties
Technology readiness level
The tetraoxane compounds have been synthesized and their structural diversity established through chemistry-driven synthesis. The biological rationale is well-supported by prior literature confirming the activity profile of 1,2,4,5-tetraoxanes. Spiro phenyl-substituted analogs are hypothesized to display similar activities based on structural analogy, with future validation planned to confirm their specific biological effects. The technology is at an early-to-mid stage of development, with proven synthesis capability and a clear pathway toward broader biological screening and application development.
About University of Ljubljana
The University of Ljubljana is a comprehensive public research university and Slovenia’s largest, anchored in the capital with extensive faculty laboratories and clinical, cultural, and technical assets. Companies engage through a central Knowledge Transfer Office that brokers collaborative R&D, IP licensing, and spin‑out pathways, complemented by the Ljubljana University Incubator for venture creation; the city’s technology park adds a dense startup and scale‑up community. Clinical translation benefits from integration with the University Medical Centre Ljubljana, enabling access to hospital‑based research and patient cohorts. Research is supported by competitive European programs and Slovenia’s national research and innovation agency (ARIS). Clearly defined commercialization routes—technology offers, industry matchmaking, and spin‑outs—help partners move from proof‑of‑concept to market.
delivered to your inbox.